Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Liu, Hai ^b   Qin, Han ^a   Chen, Guang xian ^a   Liang, Meng ya ^a   Rong, Jian ^a   Yao, Jian ping ^a   Wu, Zhong kai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Atrial fibrillation; microRNA; Rheumatic mitral valve disease

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 125B 5P; MICRORNA 133B; MICRORNA 143 3P; MICRORNA 145 5P; MICRORNA 23B 3P; MICRORNA 26A 5P; MICRORNA 30C 5P; MICRORNA 4454; MICRORNA 4484; MICRORNA 451A; MICRORNA 494; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NUCLEIC ACID DATABASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; SIGNAL TRANSDUCTION; SINUS RHYTHM; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; COMPARATIVE STUDY; DNA MICROARRAY; GENETICS; HEART ATRIUM; METABOLISM; MITRAL VALVE; PATHOLOGY; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATIC DISEASE; VALVULAR HEART DISEASE;

ATRIAL FIBRILLATION; FEMALE; GENE EXPRESSION PROFILING; HEART ATRIA; HEART VALVE DISEASES; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MITRAL VALVE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RHEUMATIC DISEASES;

EID: 84899485351     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-90     Document Type: Article

References (38)

1. Murphy NF, Simpson CR, Jhund PS, Stewart S, Kirkpatrick M, Chalmers J, MacIntyre K, McMurray JJ. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007, 93:606-612. 10.1136/hrt.2006.107573, 1955558, 17277353.
2. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002, 415:219-226. 10.1038/415219a, 11805846.
3. Wang Z, Lu Y, Yang B. MicroRNAs and atrial fibrillation: new fundamentals. Cardiovasc Res 2011, 89:710-721. 10.1093/cvr/cvq350, 21051420.
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
5. Cordes KR, Srivastava D, Ivey KN. MicroRNAs in cardiac development. Pediatr Cardiol 2010, 31:349-356. 10.1007/s00246-010-9639-3, 2836460, 20140609.
6. Wang N, Zhou Z, Liao X, Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life 2009, 61:566-571. 10.1002/iub.204, 19472179.
7. Shi B, Guo Y, Wang J, Gao W. Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction. BMC Cardiovasc Disord 2010, 10:11. 10.1186/1471-2261-10-11, 2844352, 20187981.
8. Qin H, Chen GX, Liang MY, Rong J, Yao JP, Liu H, Wu ZK. The altered expression profile of microRNAs in cardiopulmonary bypass canine models and the effects of mir-499 on myocardial ischemic reperfusion injury. J Transl Med 2013, 11:154. 10.1186/1479-5876-11-154, 3694448, 23800236.
9. Wang Z, Luo X, Lu Y, Yang B. miRNAs at the heart of the matter. J Mol Med (Berl) 2008, 86:771-783. 10.1007/s00109-008-0341-3, 2480593, 18415070.
10. Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, Shan H, Luo X, Bai Y, Sun L, Song W, Xu C, Wang Z, Yang B. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 2010, 122:2378-2387. 10.1161/CIRCULATIONAHA.110.958967, 21098446.
11. Shan H, Zhang Y, Lu Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009, 83:465-472. 10.1093/cvr/cvp130, 19398468.
12. Li H, Li S, Yu B, Liu S. Expression of miR-133 and miR-30 in chronic atrial fibrillation in canines. Mol Med Rep 2012, 5:1457-1460.
13. Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N, Lin H, Xiao L, Maguy A, Qi XY, Li Y, Gao X, Dong D, Zhang Y, Bai Y, Ai J, Sun L, Lu H, Luo XY, Wang Z, Lu Y, Yang B, Nattel S. MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest 2013, 123:1939-1951. 10.1172/JCI62185, 3635715, 23543060.
14. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010, 31:2369-2429.
15. Carabello BA. Modern management of mitral stenosis. Circulation 2005, 112:432-437. 10.1161/CIRCULATIONAHA.104.532498, 16027271.
16. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271:840-844. 10.1001/jama.1994.03510350050036, 8114238.
17. John B, Stiles MK, Kuklik P, Chandy ST, Young GD, Mackenzie L, Szumowski L, Joseph G, Jose J, Worthley SG, Kalman JM, Sanders P. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J 2008, 29:2234-2243. 10.1093/eurheartj/ehn329, 18621772.
18. Sharma D, Li G, Xu G, Liu Y, Xu Y. Atrial remodeling in atrial fibrillation and some related microRNAs. Cardiology 2011, 120:111-121. 10.1159/000334434, 22179059.
19. Xiao J, Liang D, Zhang Y, Liu Y, Zhang H, Li L, Liang X, Sun Y, Chen YH. MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 2011, 43:655-664. 10.1152/physiolgenomics.00139.2010, 21325063.
20. Liu H, Chen GX, Liang MY, Qin H, Rong J, Yao JP, Wu ZK. Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis. BMC Cardiovasc Disord 2014, 14:10. 10.1186/1471-2261-14-10, 3909014, 24461008.
21. Chapeau C, Gutkowska J, Schiller PW, Milne RW, Thibault G, Garcia R, Genest J, Cantin M. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem 1985, 33:541-550. 10.1177/33.6.3158698, 3158698.
22. Chen J, Mandapati R, Berenfeld O, Skanes AC, Gray RA, Jalife J. Dynamics of wavelets and their role in atrial fibrillation in the isolated sheep heart. Cardiovasc Res 2000, 48:220-232. 10.1016/S0008-6363(00)00177-2, 11054469.
23. Huang WJ, Zhou R, Zeng XR, Tan XQ, Cheng ZH, Tang MH, Gou LT, Chen LJ, Tong AP, He Y, Yang JL. Comparative proteomic analysis of atrial appendages from rheumatic heart disease patients with sinus rhythm and atrial fibrillation. Mol Med Rep 2011, 4:655-661.
24. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
25. Shah MY, Pan X, Fix LN, Farwell MA, Zhang B. 5-Fluorouracil drug alters the microRNA expression profiles in MCF-7 breast cancer cells. J Cell Physiol 2011, 226:1868-1878. 10.1002/jcp.22517, 21506117.
26. Zeiger U, Khurana TS. Distinctive Patterns of MicroRNA Expression in Extraocular Muscles. Physiol Genomics 2010, 41:289-296.
27. Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Caceres P, Segura A, Moreno-Herrero R, Perez-Castellanos N, Delpon E, Perez-Villacastin J, Rodriguez E, Macaya C, Lopez-Farre AJ. Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation. J Cardiovasc Electrophysiol 2010, 21:859-868.
28. Cooley N, Cowley MJ, Lin RC, Marasco S, Wong C, Kaye DM, Dart AM, Woodcock EA. Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics 2012, 44:211-219. 10.1152/physiolgenomics.00111.2011, 22147268.
29. Boutz PL, Chawla G, Stoilov P, Black DL. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 2007, 21:71-84. 10.1101/gad.1500707, 1759902, 17210790.
30. Abdellatif M. Differential expression of microRNAs in different disease states. Circ Res 2012, 110:638-650. 10.1161/CIRCRESAHA.111.247437, 3324925, 22343558.
31. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491. 10.1038/nm1569, 17401374.
32. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR. Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Heart Rhythm 2009, 6:1802-1809. 10.1016/j.hrthm.2009.08.035, 19959133.
33. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009, 104:170-178. 176p following 178, 10.1161/CIRCRESAHA.108.182535, 19096030.
34. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008, 22:3242-3254. 10.1101/gad.1738708, 2600761, 19015276.
35. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739.
36. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588. 10.1161/CIRCRESAHA.106.141986, 17478730.
37. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579. 10.1126/science.1139089, 17379774.
38. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260. 10.1073/pnas.0608791103, 1838739, 17108080.